Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: A case-control study

Blood

Volumn 95, Issue 4, 2000, Pages 1222-1228

  Stanulla, Martin ^a   Schrappe, Martin ^a   Müller Brechlin, Annette ^a   Zimmermann, Martin ^a   Welte, Karl ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; GLUTATHIONE TRANSFERASE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT;

EID: 0034651551     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1222.004k20_1222_1228     Document Type: Article

References (49)

1. Ketterer B. The protective role of glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202:343.
2. Hengstler JG, Arand M, Herrero ME, Oesch F. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase, and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res. 1998; 154:47.
3. Mannervik B, Awasthi YC, Board PG, et al. Nomenclature for human glutathione transferases. Biochem J. 1992;282:305.
4. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A. 1988;85:7293.
5. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300:271.
6. Board PG, Webb GC, Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 gene to chromosome bands 11q13 and 12q13-14. Ann Hum Genet. 1989;53:205.
7. Ali-Osman F, Akande O, Antoun G, Mao J-X, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full length cDNAs of three human glutathione S-transferase pi gene variants. J Biol Chem. 1997;272:10,004.
8. Lo HW, Ali-Osman F. Genomic cloning of hGSTP1*C, an allelic human Pi class glutathione S-transferase gene variant, and functional characterization of its retinoic acid response elements. J Biol Chem. 1997;272:32,743.
9. Watson MA, Stewart RK, Smith GBJ, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationships to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998;19:275.
10. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18:641.
11. Zimniak P, Nanduri B, Pikula S, et al. Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucin and valine in position 104 differ in enzymic properties. Eur J Biochem. 1994;224:893.
12. Hu X, Xia H, Srivastava SK, et al. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun. 1997;238:397.
13. Perera F. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst. 1996;88:496.
14. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis. 1990;11:33.
15. Nazar-Stewart V, Motulsky AG, Eaton DL, et al. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res. 1993;53.2313.
16. Bell DA, Taylor J, Paulson DF, Robertson CN, Mohler JF, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993;85: 1159.
17. Ambrosone CB, Freudenheim JL, Graham S, et al. Cytochrome P450 1A1 and glulathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 1995;55:3483.
18. Kelsey KT, Hankinson SE, Colditz GA, et al. Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev. 1997;6:511.
19. Helzlsouer KJ, Selmin O, Huang H-Y, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancel. J Natl Cancer Inst. 1998; 90:512.
20. Strange RC, Matharoo B, Faulder GC, et al. The human glutathione S-transferases: a case-control study of the incidence of the GST1 theta phenotype in patients with adenocarcinoma. Carcinogenesis. 1991;12:25.
21. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881.
22. Tew KD. Glutathione-associated enzymes in anti-cancer drug resistance. Cancer Res. 1994;54: 4313.
23. Iyer L, Ratain MJ. Pharmacogenetics and cancer chemotherapy Eur J Cancer. 1998;34:1493.
24. Yuan Z-M, Smith PB, Brundrett RB, Colvin M, Fenselau C. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. Drug Metab Dispos. 1991;19:625.
25. Listowsky I. High capacity binding by glutathione S-tranferases and glucocorticoid resistance. In: Tew KD, Pickett CB, Mantle TJ, Mannervik B, Hayes JD, eds. Structure and Function of Glutathione Transferases. Boca Raton, FL: CRC Press; 1993:199.
26. Nakagawa K, Saijo N, Tsuchida S, et al. Glutathione S-transferase π as a determinant of drug resistance in transfectant cell lines. J Biol Chem. 1990;265:4296.
27. Black SM, Beggs JD, Hayes JD, et al. Expression of human glutathione S-transferase in Saccharomyces cerevisiae confers resistance to the anti-cancer drugs adriamycin and chlorambucil. Biochem J. 1990;268:309.
28. Pui C-H. Childhood leukemias. N Engl J Med. 1995;332:1618.
29. Kersey JH. Fifty years of studies of the biology and therapy of childhood leukemia. Blood. 1997; 90:4243.
30. Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994;84:3122.
31. Schrappe M, Reiter A, Sauter S, et al. Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprech-ens in Blut und Knochenmark. Klin Pädiatr. 1994; 206:208.
32. Schrappe M, Reiter A, Welte K, et al. Risk adapted treatment in childhood acute lymphoblastic leukemia: data from the Berlin-Frankfurt-Münster group. In: Büchner T, Hiddemann W, Wörmann B, Scnellong G, Ritter J, Creutzig U, eds. Hematology and Blood Transfusion. Vol 38. Acute Leukemias VI: Prognostic Factors and Treatment Strategies. New York, NY: Springer; 1997:601.
33. Chen C-L, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 1996;6:187.
34. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 1998;8:27.
35. Chen C-L, Liu Q, Pui C-H, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood. 1997;89:1701.
36. Hall AG, Autzen P, Cattan AR, et al. Expression of μ class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia. Cancer Res. 1994;54:5251.
37. Joncourt F, Oberli A, Redmond SMS, et al. Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkyl-guanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukemia. Br J Haematol. 1993;85:103.
38. Sauerbrey A, Zintl F, Volm M. P-glycoprotein and glutathione S-transferase π in childhood acute lymphoblastic leukaemia. Br J Cancer. 1994;70: 1144.
39. Russo D, Marie JP, Zhou DC, et al. Evaluation of the clinical relevance of the anionic glutathione S-transferase (GSTπ) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomas. Leuk Lymphoma. 1994;15:453.
40. Ribrag V, Massade V, Faussat AM, et al. Drug resistance mechanisms in chronic lymphocytic leukemia. Leukemia. 1996;10:1944.
41. Charrier J, Maugard CM, Le Mevel B, Bignon YJ. Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility. Br J Cancer. 1999;79:346.
42. Brockmöller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione S-transferase M1 and its variants A and Bas host factors of bladder cancer susceptibility: a case-control study. Cancer Res. 1994;54:4103.
43. Shpilberg O, Dorman JS, Shahar A, Kuller LH. Molecular epidemiology of hematological neoplasms-present status and future directions. Leukemia Res. 1997;21:265.
44. Schröder KR, Wiebel FA, Reich S, Dannappel DMBH, Hallier E. Glutathione S-transferase (GST) theta polymorphism influences background SCE rate. Arch Toxicol. 1995;69:505.
45. Wiencke JK, Pemble S, Ketterer B, Kelsey KT. Gene deletion of glutathione S-transterase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev. 1995;4:253.
46. Lautier D, Canitrot Y, Deelay RG, Cole SPC. Multidrug resistance mediated by the multidrug resistance protein (MRP) gene. Biochem Pharmacol. 1996;52:967.
47. Morrow CS, Smitherman PK, Diah SK, Schneider E, Townsend AJ. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. J Biol Chem. 1998;273:20,114.
48. Dirven HA, Megens L, Oudshoorn MJ, et al. Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases. Chem Res Toxicol. 1995;8:979.
49. Hall AG, Tilby MJ. Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies. Blood Rev. 1992;6:163.